Plain-English translation of NCT03892993 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers at M.D. Anderson Cancer Center are building a decision aid — a tool designed to help patients with medullary thyroid cancer work through important medical choices with their doctors. The aid will help guide conversations about whether to start a new drug, stop a drug, join a clinical trial, or continue with active surveillance (careful watching without immediate treatment). Researchers want to make sure this tool is easy to use and actually helpful for real patients and their families.
Patients with medullary thyroid cancer often face complex decisions about their treatment path, and these conversations can feel overwhelming without proper support. This trial aims to create a resource that helps patients, caregivers, and doctors talk through options together in a clearer, more organized way.
You likely qualify if…
You likely don't qualify if…
Your participation would involve using the decision aid tool (either on paper or on a computer) and then completing questionnaires about what you thought of it — how easy it was to understand, whether it helped you think through your options, and what might make it better. The study team will ask for your honest feedback to refine the tool before it's used more widely. There are no medications to take or invasive procedures involved; it's all about gathering input to build a better support tool for future patients.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
United States